Skip to main content
TipRanks
Go Ultimate75% OFF

Intuitive Surgical (ISRG) Operating Expense Breakdown

9,889 Followers

Operating Expense Breakdown

Intuitive Surgical reported operating expenses of $1.49B in Q3 2026, up 50.9% from Q2 2026 and up 65.2% year over year. This is the highest value since 2018.

Details spending on R&D, sales and marketing, and general administration to show how the company is allocating cash; rising R&D and sales spend can fuel long-term growth but may pressure short-term profitability if not matched by revenue gains.

$0.00$250.00M$500.00M$750.00M$1.00B$1.25B$1.50BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

R&D has been accelerating faster than SG&A, signaling deliberate investment behind da Vinci 5, SP/XiR and ION — management explicitly said R&D will outpace SG&A. SG&A also trends up with pronounced December-quarter step‑ups tied to comp and seasonal costs; guidance for 11–13% non‑GAAP op‑expense growth and ~$880–$900M of noncash stock comp makes future quarters sensitive to timing. Investors should watch whether procedure/revenue momentum sustains to absorb higher R&D intensity and avoid margin pressure once one‑time items (tariff refund, Foundation gift) are excluded.

ISRG Operating Expense Breakdown

PeriodResearch and DevelopmentSelling, General, and AdministrativeTotal
Q3 2026Sep 30, 2026$408.30M$1.08B$1.49B
Q2 2026Jun 30, 2026$370.60M$617.90M$988.50M
Q1 2026Mar 31, 2026$361.90M$613.30M$975.20M
Q4 2025Dec 31, 2025$352.90M$687.10M$1.04B
Q3 2025Sep 30, 2025$329.40M$573.30M$902.70M
Q2 2025Jun 30, 2025$313.30M$561.20M$874.50M
Q1 2025Mar 31, 2025$316.20M$563.40M$879.60M
Q4 2024Dec 31, 2024$294.70M$612.60M$907.30M
Q3 2024Sep 30, 2024$286.00M$510.60M$796.60M
Q2 2024Jun 30, 2024$280.10M$525.30M$805.40M
Q1 2024Mar 31, 2024$284.50M$491.50M$776.00M
Q4 2023Dec 31, 2023$260.10M$567.10M$827.20M
Q3 2023Sep 30, 2023$249.40M$452.00M$701.40M
Q2 2023Jun 30, 2023$244.40M$464.30M$708.70M
Q1 2023Mar 31, 2023$244.90M$480.50M$725.40M
Q4 2022Dec 31, 2022$244.10M$494.30M$738.40M
Q3 2022Sep 30, 2022$217.10M$436.10M$653.20M
Q2 2022Jun 30, 2022$207.30M$418.40M$625.70M
Q1 2022Mar 31, 2022$210.50M$391.10M$601.60M
Q4 2021Dec 31, 2021$183.40M$427.00M$610.40M
Q3 2021Sep 30, 2021$165.50M$363.30M$528.80M
Q2 2021Jun 30, 2021$162.30M$350.20M$512.50M
Q1 2021Mar 31, 2021$159.80M$326.00M$485.80M
Q4 2020Dec 31, 2020$149.80M$330.20M$480.00M
Q3 2020Sep 30, 2020$155.00M$298.90M$453.90M
Q2 2020Jun 30, 2020$143.20M$279.10M$422.30M
Q1 2020Mar 31, 2020$147.10M$308.10M$455.20M
Q4 2019Dec 31, 2019$156.60M$341.80M$498.40M
Q3 2019Sep 30, 2019$135.90M$284.00M$419.90M
Q2 2019Jun 30, 2019$120.80M$279.20M$400.00M
Q1 2019Mar 31, 2019$144.00M$273.40M$417.40M
Q4 2018Dec 31, 2018$119.90M$283.80M$403.70M
Q3 2018Sep 30, 2018$107.60M$221.40M$329.00M
Q2 2018Jun 30, 2018$95.10M$259.80M$354.90M
Q1 2018Mar 31, 2018$273.40M$221.60M$495.00M

Related KPIs